KALISTA TROMBLEY ENGELMAN DO NPI 1043440944

NPI Information

  • NPI: 1043440944
  • Provider Name: KALISTA TROMBLEY ENGELMAN, DO
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4440 BROADWAY BLVD
    KANSAS CITY, MO
    ZIP 64111
  • Phone: (816) 531-0930

Map and Directions

Get Directions

NPI Details

Kalista Trombley Engelman, DO is a rheumatology internal medicine in Kansas City, MO with 10 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Kalista Trombley Engelman, DO NPI is 1043440944. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:2015

The provider's business location address is:

4440 BROADWAY BLVD
KANSAS CITY, MO
ZIP 64111-315
Phone: (816) 531-0930
Fax: (816) 753-2671

The NPI 1043440944 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood creatinine level (HCPCS:82565)
  • Liver function blood test panel (HCPCS:80076)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Uric acid level, blood (HCPCS:84550)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection of additional new drug or substance into vein (HCPCS:96375)

The enumeration date for this NPI number is 7/26/2009 and was last updated on 3/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology2015001548MISSOURIYes
2207RR0500XInternal MedicineRheumatology05-36624KANSASNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.